Fertility Preservation in Female Patients with Cancer. Part II: Royan Institute Clinical Practice Guideline for Girls and Women with Cancer; A Review Study

Document Type : Review Article

Authors

1 Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for reproductive biomedicine, ACECR, Tehran, Iran.

2 Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

10.22074/ijfs.2024.2015631.1570

Abstract

The fertility preservation is a paramount concern for oncology patients and should be regarded as an essential component of their overall cancer management strategy. The magnitude of this issue has been recognized in fertility preservation guidelines. The formulation and execution of harmonized guidelines and policies concerning the provision of fertility preservation services, inclusive of therapeutic strategies and standardization of procedures, are crucial to surmount disagreements regarding the delivery of these therapeutic services and avert delays in cancer treatment. The matter of fertility preservation and the methodology for managing the treatment and follow-up of cancer patients should be documented as a component of their management guideline, thereby providing patients with clear recommendations on fertility preservation. In this manuscript, we provide a succinct overview of existing international guidelines history and reference comprehensive networks of fertility preservation services for oncology patients. Furthermore, we present the Royan Institute’s guideline specifically designed for preserving the fertility of female oncology patients.

Keywords

Main Subjects